The Nurse’s Role in Inflammatory Bowel Disease

Slides:



Advertisements
Similar presentations
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.
Advertisements

(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2015 Comparison of (Your site name) results against the national results.
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2015 Comparison of (Your site name) results against the national results.
R3. 최태웅 / Pf. 김효종 Alimentary Pharmacology & Therapeutics 19 FEB 2016 DOI: /apt.13547
The Patient Experience With Systemic Lupus Erythematosus
The Nurse View: Management of Pancreatic Cancer
The Nurse View.
IBD Therapies: Guidance for Managed Care Professionals
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
IL-12 and IL-23.
The Nurse View Key Insights Along the CML Continuum
The Clinical Enigma of Cardiogenic Shock
Goals of Therapy for Patients With UC
Optimizing Use of Biological Agents in Ulcerative Colitis
Changing the IBD Paradigm
Unmet Needs in the Secondary Prevention in ACS
Medication Nonadherence in Gout
Complicated Cases in Ulcerative Colitis
Managing IBD in Children
Optimizing Patient Outcomes in IBD
Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams
IL-17 Inhibitors in the Management of Psoriatic Disease
When Would You Use Single Inhaler Triple Therapy in COPD?
Checkpoint Inhibition
Talking to Patients About Diabetes Management
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
HCV Protease Inhibitors in Clinical Practice
Team-Based Perspectives on Successful Approaches in Treating Obesity
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Is RA Treatment Addressing the Real Needs of Patients?
Managing IBD.
Understanding PAD.
Program Goals. Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer.
Remote Patient Management:
Optimizing Outcomes and Managing Adverse Events in CLL
Anti-integrin therapy in inflammatory bowel disease
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
Advancing the Treatment of IBD With Biologics
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Management of Systematic Lupus Erythematosus
Aspirin and Cardioprevention in 2018
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Best Clinical Pearls in Hidradenitis Suppurativa:
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Early Referral for Patients With IBD Failing Conventional Therapies
IBD Increases Risk for Vaccine-Preventable Diseases
Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.
Optimizing Outcomes in Crohn Disease
HCV Protease Inhibitors in Clinical Practice
Application of Biologics in IBD:
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
LDL Cholesterol.
Incorporating Prostacyclins Into Practice
Improving Adherence to Antiplatelet Therapy After an ACS Event
Clinical Challenges and Updates in Managing Seizure Clusters
Pathogenesis of IBD, and the Role of Biologic Therapies
Volume 140, Issue 6, Pages e2 (May 2011)
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Targeting IL-23 for Therapeutic Longevity in Psoriasis
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.
Examining the Role of Pharmacokinetics in Hemophilia
Navigating the Journey
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
Fresh perspectives ON BASAL Insulins in diabetes care
Patient Heterogeneity in CD
Women With Psoriasis Are Struggling More Than Men
Presentation transcript:

The Nurse’s Role in Inflammatory Bowel Disease

Etiologic Theories in IBD

IBD Clinical Characteristics

Extraintestinal Manifestations of IBD

Biologics: Anti–TNF-α and Anti-Integrins

Risk Factors for Aggressive Disease (Crohn Disease)

Safety Concerns With Anti–TNF-α Therapy

Adverse Events With Vedolizumab

How to Discuss Risk With Patients

The Nurse’s Role in Administering Biologics

Measuring Response to Biologic Therapy

Cost of Nonadherence

When Are Infusion Delays Appropriate?

Avoid Infusion Delays Related to Patient Insurance

Role of Nurses in IBD Care

The IBD Care Team

Summary

Abbreviations

Abbreviations (cont)